$RDVT

Red Violet, Inc. (RDVT): Results of Operations and Financial Condition

Red Violet, Inc. (RDVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K false 0001720116 0001720116 2026-08-05 2026-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of e

Original reporting
Published Aug 5, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 5:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RDVT
Bullish
medium confidence
Mentioned
$RDVT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RDVTBullishMed
01

Why it matters

This creates a fresh, quarter-specific reference point for investors ahead of the final reported interim results, potentially affecting near-term valuation and expectations for profitability and operating leverage.

02

Market read

Traders can update short-term expectations using the disclosed estimated revenue, net income, and adjusted EBITDA, while accounting for the stated risk that actual results may differ.

03

What to watch

Adjusted EBITDA excludes multiple items and the filing provides only estimates, so the key risk is whether final GAAP results diverge materially from the preliminary profitability and margin figures.

Relevance 7/10Novelty 7/10Timing: after-hours filing on Aug 5, 2026 for the quarter ended June 30, 2026

Background

The company furnished preliminary, unaudited financial results for the three months ended June 30, 2026 via an SEC Form 8-K (Item 2.02 / Item 7.01).

Company-level read

Ticker impact

$RDVTBullishMedium confidence
Context

Red Violet filed an 8-K with preliminary Q2 2026 results, estimating revenue of $26.71M and net income of $4.96M.

Expected impact

Likely modest positive bias into the final earnings release, with volatility risk due to the preliminary, unaudited nature of the numbers.

Evidence & confidence

The filing discloses concrete estimated revenue, net income, and adjusted EBITDA for the quarter, which can move expectations. However, the company warns results are preliminary and not audited/reviewed, limiting conviction.

Market effects

Limited broader sector read-through because the disclosure is company-specific and does not include guidance or industry-wide signals.

No clear regional spillover beyond small-cap NASDAQ sentiment for the issuer.

Minimal global relevance; disclosure is confined to the company’s quarterly financial condition.

Counterpoint

Because the numbers are preliminary and explicitly subject to change, traders may fade the initial optimism and wait for the final interim financial statements to confirm margins and EBITDA quality.

Key entities

  • Red Violet, Inc.

    NASDAQ-listed issuer filing an 8-K with preliminary Q2 2026 revenue, net income, and adjusted EBITDA estimates.

  • Grant Thornton LLP

    Independent registered public accounting firm stated it has not audited or reviewed the preliminary results.

Related articles

$RDVTMedAI 8/10

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option

Red Violet, Inc. (NASDAQ: RDVT) said it closed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares from full exercise of the underwriters’ option. The company estimates net proceeds of about $108.6 million. Proceeds will be used for working capital, general corporate purposes, and potential strategic acquisitions.

$RDVTMedAI 8/10

red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Red Violet, Inc. (NASDAQ: RDVT) priced an underwritten public offering of 1,666,667 shares of common stock at $60.00 per share, raising expected gross proceeds of $100 million before underwriting fees and expenses. The offering is expected to close Aug. 7, 2026, with a 30-day option for up to 250,000 additional shares. Net proceeds will fund working capital and corporate purposes.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.